An unusual about-face that played out at the FDA over the last week illustrated the power of the “Make America Healthy Again” ...

Diagnostics' progress on their PCR platform, with key trials in 2025 and commercialization plans by 2026, targeting U.S. and global markets.

Research and Development Expenses-- $4,700,000 compared to $5,600,000 during the prior year comparable period. Kodiak PCR ...

Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC) has officially entered the most critical phase of its development ...

Bombshell at RENK! Order intake is exploding! Revenue and earnings are also already up significantly. After Rheinmetall and ...

Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of ...

The Series 10 offers the most variety of Apple's smartwatches, giving you the choice of two metals for the case, aluminum or ...

In an era focused on health and wellness, parents are more concerned than ever about what exactly is going into their children’s multivitamins.

PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of ketamine, announced today ...

TuHURA Biosciences, Inc. (NASDAQ: HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel ...

MediPharm Labs Corp. shares T.LABS are trading down $0.02 at $0.08.

AutoCanada Inc. (T.ACQ) hit a new 52-week high of $32.43 AutoCanada rose 11% on volume of 128,913 shares. Aimia ...